DPIIT recognised startup Government of India
Startup India
Transcell Biolife Private Limited - life sciences in Hyderabad, Telangana, India. Directors, charges & compliance details.
Revenue · FY 2023
₹2.88 Cr
▼ 45% YoY
Net profit · FY 2023
₹5.74 Lakh
Net margin 2%
EBITDA · FY 2023
₹29.3 Lakh
EBITDA margin 10.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹1 Cr
Secured borrowings
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
About Transcell Biolife Private Limited
Data last updated:
Transcell Biolife Private Limited was a private limited company based in Hyderabad, Telangana, India, operated as a subsidiary of Tran-Scell Biologics Private Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the biotechnology segment of the life sciences sector. It was incorporated on 03 August 2017.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2017PTC118697. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Gorthi Leelakrishna and Subhadra Dravida.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at 8th Floor Western Pearl Kondapur, Hyderabad, Telangana, India – 500084.
As per the financials filed for FY 2023, the company reported a revenue of ₹2.88 Cr, a decline of 45% compared to the previous year. For the same year it recorded a net profit of ₹5.74 Lakh (net margin 2%) and EBITDA of ₹29.3 Lakh (EBITDA margin 10.2%). Revenue has declined at a compounded annual rate (CAGR) of 38% over three years and 8% over five years.
The company was associated with 1 brand: Transcell Biosciences. As per MCA filings, the company had open charges of ₹1 Cr on record. Court records list 1 case involving the company, including 1 filed by the company.
The last known website on record is transcell.in.
Company details
CIN U74999TG2017PTC118697
Registration Number 118697
Incorporation Date 03 August 2017
ROC Hyderabad
Listing Status Unlisted
Company Status Amalgamated
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
Parent Company Tran-Scell Biologics Private Limited
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
Recognitions & Rankings of Transcell Biolife
Contact details
Transcell Biolife Private Limited's registered office is in Hyderabad, Telangana. Its website is transcell.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address8th Floor Western Pearl Kondapur, Hyderabad, Telangana, India – 500084
- IndustryLife Sciences, Biotechnology
To see the full contact details of Transcell Biolife Private Limited, buy the company report.
Comprehensive company report
Transcell Biolife Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Transcell Biolife operates one associated brand: Transcell Biosciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Stem cell banking and biobanking services are provided by Transcell Biosciences. | transcell.in |
Business activity
The main business activity of Transcell Biolife is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Transcell Biolife Private Limited, buy the company report.
Financials of Transcell Biolife Private Limited
FY 2023 filings availableTranscell Biolife Private Limited reported revenue of ₹2.88 Cr (down 45% YoY) for FY 2023.
Revenue · FY 2023
₹2.88 Cr ▼ 45%
Net profit · FY 2023
₹5.74 Lakh margin 2%
EBITDA · FY 2023
₹29.3 Lakh margin 10.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 45%
3 years · compounded
▼ 38%
5 years · compounded
▼ 8%
EBITDA CAGR growth
1 year
▼ 21%
3 years · compounded
▼ 7%
5 years · compounded
▲ 13%
Revenue has declined at a compounded annual rate (CAGR) of 8% over five years, including a 45% fall in the latest year. EBITDA fell 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹29.3 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.74 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.2% | ||||
| Net Profit Margin | 2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Transcell Biolife Private Limited, buy the company report.
Board of directors of Transcell Biolife Private Limited
Transcell Biolife has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Directors (as last reported)
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gorthi Leelakrishna | Director | 25 Jan 2022 | 4 Years 9 Months | As last reported |
| Subhadra Dravida | Director | 03 Aug 2017 | 9 Years 2 Months | As last reported |
Auditor
Transcell Biolife Private Limited is audited by Kavadapu and Associates for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Kavadapu and Associates | FY 2022 | 017380S |
Shareholding
The shareholding of Transcell Biolife Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Transcell Biolife Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Nov 2019 | 100302080 | Hdfc Bank Limited | ₹1 Cr | Open |
Total charge records: 1 View all charges
Legal cases
Transcell Biolife Private Limited has 1 court case on record: 1 filed by Transcell Biolife. All case is disposed.
Total cases
1
Filed by the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLT | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Hyderabad | Court case (C.P.(CAA)) | Filed by the company | Disposed |
To see the full case history of Transcell Biolife Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Transcell Biolife Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Transcell Biolife has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
Total GSTINs
1
Cancelled / inactive
1
To see the full GST registrations and return filing status of Transcell Biolife Private Limited, buy the company report.
Recent activity
Transcell Biolife Private Limited has 4 board changes on record since 2017: 2 appointments and 2 cessations. The latest: Gorthi Leelakrishna ceased to be Additional Director on 30 Sep 2022.
AGM
Transcell Biolife Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Transcell Biolife Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
Ceased
Gorthi Leelakrishna ceased to be Additional Director.
Appointed
Gorthi Leelakrishna was appointed as Director.
Ceased
Vinayender Tulla ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 100.00 Lakh with Charge ID 100302080 was registered on 05 Nov 2019.
Appointed
Subhadra Dravida was appointed as Director.
Incorporation
03 Aug 2017
Transcell Biolife Private Limited was registered on 03 Aug 2017 with Roc Hyderabad & aged 9 years 2 months as per MCA records.
News
Frequently asked questions
Transcell Biolife has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Transcell Biolife was a private limited company based in Hyderabad, Telangana, India. The company worked in biotechnology, within the life sciences industry. It was incorporated on 03 August 2017 and is registered under CIN U74999TG2017PTC118697. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Transcell Biolife was incorporated on 03 August 2017. It is registered with the Registrar of Companies, Hyderabad.
Transcell Biolife had 2 directors:
- Gorthi Leelakrishna - Director
- Subhadra Dravida - Director
The CIN (Corporate Identification Number) of Transcell Biolife is U74999TG2017PTC118697. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Transcell Biolife is at 8th Floor Western Pearl Kondapur, Hyderabad, Telangana, India – 500084.
Yes, Transcell Biolife is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Transcell Biolife can be reached through the website transcell.in. Its registered office is in Hyderabad, Telangana, India.
The latest financial statements of Transcell Biolife on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2018 are in the company report.
No. Transcell Biolife has 1 GST registration on record and it is cancelled or inactive.